https://www.umassmed.edu/vitiligo/blog/blog-posts1/2015/12/ruxolitinib-jakafi-for-vitiligo/
We recently published a report about a vitiligo patient who quickly improved after taking ruxolitinib (Jakafi), a drug that inhibits Janus Kinases (JAKs),...
a newspeakingvitiligoblogruxolitinib
https://www.ajmc.com/view/fda-grants-ruxolitinib-priority-review-to-treat-chronic-gvhd
The FDA has granted priority review of the supplemental New Drug Application for ruxolitinib for the treatment of steroid-refractory chronic graft-versus host...
priority reviewfdagrantsruxolitinibtreat
https://www.ajmc.com/view/ruxolitinib-cream-holds-potential-for-children-with-more-severe-atopic-dermatitis-lawrence-eichenfield-md
The efficacy of ruxolitinib cream in pediatric patients shows that nonsteroidal management of atopic dermatitis is feasible, said Lawrence Eichenfield, MD,...
for childrenruxolitinibcreamholdspotential